Coherus BioSciences
CHRS
#10164
Rank
A$86.21 M
Marketcap
A$0.56
Share price
-4.47%
Change (1 day)
-71.85%
Change (1 year)

P/S ratio for Coherus BioSciences (CHRS)

P/S ratio as of November 2026 (TTM): 1.12

According to Coherus BioSciences 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.9394. At the end of 2026 the company had a P/S ratio of 4.54.

P/S ratio history for Coherus BioSciences from 2014 to 2026

PS ratio at the end of each year

Year P/S ratio Change
20264.5415.68%
20253.9366.52%
20242.3663.57%
20231.44-50.61%
20222.92-22.22%
20213.7542.61%
20202.63-26.04%
20193.56
2018N/A-100%
20173325037.79%
20166.46-78.32%
201529.870.85%
201417.4

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Amgen
AMGN
6.06 439.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
13.0 1,058.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
0.0071-99.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA